Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 6797 Winchester Circle BOULDER CO 80301 |
Tel: | N/A |
Website: | https://www.encision.com |
IR: | See website |
Key People | ||
Gregory J. Trudel President, Chief Executive Officer, Director | David W. Newton Co-Founder, Vice President - Technology, Director | Mala M Ray Vice President - Controller, Treasurer, Company Secretary |
Jason Johnson Vice President of Sales | Brian Jackman Vice President of Marketing |
Business Overview |
Encision Inc. is a medical device company. The Company designs, develops, manufactures and markets patented surgical instruments that provide safety to patients undergoing minimally invasive surgery. Its segments include product and service. Product designs, develops, manufactures and markets patented surgical instruments. Service performs electrical engineering activities for external entities. Its Active Electrode Monitoring (AEM) technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures, while preventing stray electrosurgical energy that can cause complications and even death. Its shielded and monitored instruments enable surgeons to perform electrosurgical procedures. It has developed and launched AEM Surgical Instruments and Monitors for laparoscopic surgical procedures. It is also engaged in various manufacturing and assembly activities at its leased facility in Boulder, Colorado. |
Financial Overview |
For the nine months ended 31 December 2023, Encision Inc revenues decreased 9% to $5.1M. Net loss increased 54% to $355K. Revenues reflect Service segment decrease of 71% to $134K, Product segment decrease of 3% to $4.9M. Higher net loss reflects Service segment income decrease of 94% to $29K. Basic Earnings per Share excluding Extraordinary Items decreased from -$0.02 to -$0.03. |
Employees: | 31 as of Mar 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $9.01M as of Dec 31, 2023 |
Annual revenue (TTM): | $6.87M as of Dec 31, 2023 |
EBITDA (TTM): | -$0.30M as of Dec 31, 2023 |
Net annual income (TTM): | -$0.45M as of Dec 31, 2023 |
Free cash flow (TTM): | -$0.00M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $0.18M as of Dec 31, 2023 |
Shares outstanding: | 11,769,543 as of Dec 31, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |